Olanzapine plus triple antiemetic therapy for prevention of carboplatin-induced nausea: a pooled analysis of two clinical trials

Abstract Background Chemotherapy-induced nausea and vomiting is a common adverse event of cancer treatments. Despite prophylactic antiemetic treatment, nausea remains a particular problem. We aimed to identify risk factors and clarify the usefulness of olanzapine for the control of carboplatin-induc...

Descripció completa

Dades bibliogràfiques

Autors principals:	Suguru Kojima, Naoki Inui, Takahito Suzuki, Kazuki Tanaka, Masato Karayama, Yusuke Inoue, Hideki Yasui, Hironao Hozumi, Yuzo Suzuki, Kazuki Furuhashi, Tomoyuki Fujisawa, Noriyuki Enomoto, Koji Nishimoto, Shun Matsuura, Dai Hashimoto, Takashi Matsui, Kazuhiro Asada, Takafumi Suda
Format:	Artigo
Idioma:	Inglês
Publicat:	BMC 2025-10-01
Col·lecció:	BMC Cancer
Matèries:	Antiemetic Carboplatin Chemotherapy-induced nausea and vomiting Nausea Olanzapine Risk factor
Accés en línia:	https://doi.org/10.1186/s12885-025-14985-1
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!